The Wip1 phosphatase acts as a gatekeeper in the p53-Mdm2 autoregulatory loop

被引:239
作者
Lu, Xiongbin [1 ]
Ma, Ou
Nguyen, Thuy-Ai
Joness, Stephen N.
Oren, Moshe
Donehower, Lawrence A.
机构
[1] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA
[2] Baylor Coll Med, Interdept Program Cell & Mol Biol, Houston, TX 77030 USA
[3] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA
[4] Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA
[5] Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA 01655 USA
[6] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel
基金
美国国家卫生研究院;
关键词
D O I
10.1016/j.ccr.2007.08.033
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The tumor suppressor p53 is a transcription factor that responds to cellular stresses by initiating cell cycle arrest or apoptosis. One transcriptional target of p53 is Mdm2, an E3 ubiquitin ligase that interacts with p53 to promote its proteasomal degradation in a negative feedback regulatory loop. Here we show that the wild-type p53-induced phosphatase 1 (Wipl), or PPM1 D, downregulates p53 protein levels by stabilizing Mdm2 and facilitating its access to p53. Wipl interacts with and dephosphorylates Mdm2 at serine 395, a site phosphorylated by the ATM kinase. Dephosphorylated Mdm2 has increased stability and affinity for p53, facilitating p53 ubiquitination and degradation. Thus, Wipl acts as a gatekeeper in the Mdm2-p53 regulatory loop by stabilizing Mdm2 and promoting Mdm2-mediated proteolysis of p53.
引用
收藏
页码:342 / 354
页数:13
相关论文
共 51 条
  • [1] Post-translational modifications and activation of p53 by genotoxic stresses
    Appella, E
    Anderson, CW
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 2001, 268 (10): : 2764 - 2772
  • [2] Chemical inhibition of Wip1 phosphatase contributes to suppression of tumorigenesis
    Belova, GI
    Demidov, ON
    Fornace, AJ
    Bulavin, DV
    [J]. CANCER BIOLOGY & THERAPY, 2005, 4 (10) : 1154 - 1158
  • [3] Post-translational modification of p53 in tumorigenesis
    Bode, AM
    Dong, ZG
    [J]. NATURE REVIEWS CANCER, 2004, 4 (10) : 793 - 805
  • [4] MDM2 is a central node in the p53 pathway: 12 years and counting
    Bond, GL
    Hu, WW
    Levine, AJ
    [J]. CURRENT CANCER DRUG TARGETS, 2005, 5 (01) : 3 - 8
  • [5] Inactivation of the Wip1 phosphatase inhibits mammary tumorigenesis through p38 MAPK-mediated activation of the p16Ink4a-p19Arf pathway
    Bulavin, DV
    Phillips, C
    Nannenga, B
    Timofeev, O
    Donehower, LA
    Anderson, CW
    Appella, E
    Fornace, AJ
    [J]. NATURE GENETICS, 2004, 36 (04) : 343 - 350
  • [6] Amplification of PPM1D in human tumors abrogates p53 tumor-suppressor activity
    Bulavin, DV
    Demidov, ON
    Saito, S
    Kauraniemi, P
    Phillips, C
    Amundson, SA
    Ambrosino, C
    Sauter, G
    Nebreda, AR
    Anderson, CW
    Kallioniemi, A
    Fornace, AJ
    Appella, E
    [J]. NATURE GENETICS, 2002, 31 (02) : 210 - 215
  • [7] Activation of the ATM kinase by ionizing radiation and phosphorylation of p53
    Canman, CE
    Lim, DS
    Cimprich, KA
    Taya, Y
    Tamai, K
    Sakaguchi, K
    Appella, E
    Kastan, MB
    Siliciano, JD
    [J]. SCIENCE, 1998, 281 (5383) : 1677 - 1679
  • [8] Chehab NH, 2000, GENE DEV, V14, P278
  • [9] The structure and expression of the murine wildtype p53-induced phosphatase 1 (Wip1) gene
    Choi, J
    Appella, E
    Donehower, LA
    [J]. GENOMICS, 2000, 64 (03) : 298 - 306
  • [10] Mice deficient for the wild-type p53-induced phosphatase gene (Wip1) exhibit defects in reproductive organs, immune function, and cell cycle control
    Choi, J
    Nannenga, B
    Demidov, ON
    Bulavin, DV
    Cooney, A
    Brayton, C
    Zhang, YX
    Mbawuike, IN
    Bradley, A
    Appella, E
    Donehower, LA
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2002, 22 (04) : 1094 - 1105